Australia legalizes psychedelics, setting a global precedent.

Australia Legalizes and Regulates MDMA and Psilocybin Mushrooms

Australia has taken a groundbreaking step by legalizing and regulating the use of MDMA and psilocybin mushrooms. Starting from July 1, doctors will be able to prescribe these substances for specific medical conditions.

Prescriptions for PTSD and Treatment-Resistant Depression

MDMA, commonly known as ecstasy, will only be prescribed to patients who are seeking treatment for post-traumatic stress disorder. Psilocybin mushrooms, on the other hand, will be prescribed to patients who have experienced treatment-resistant depression.

Before prescribing these substances, every psychiatrist must obtain approval from a Human Research Ethics Committee affiliated with the National Health and Medical Research Council.

Not Eligible for Government Subsidies

It’s important to note that the newly legalized drugs will not be eligible for listing on the Pharmaceutical Benefits Scheme, which is a list of medications subsidized by the Australian government.

Psilocybin, found in mushrooms, is relatively inexpensive. However, its treatment protocol involves thorough assessment and ongoing psychotherapeutic management by the psychiatrist, both before and after administration. This could contribute to the overall treatment cost.

Research and Legalization Efforts

The Center for Psychedelic and Consciousness Research at Johns Hopkins University has conducted extensive research on psilocybin as a potential treatment for depression, anxiety, and nicotine addiction.

It’s worth mentioning that Colorado and Oregon have also legalized psilocybin mushrooms, and several cities, including Denver and Washington, D.C., have passed local measures decriminalizing certain psychedelics.

MDMA: A Synthetic Drug with Risks

Unlike psilocybin mushrooms, MDMA is a synthetic drug that was initially developed as an appetite suppressant. It is both a hallucinogenic and a stimulant, requiring close supervision due to potential risks.

Users of MDMA are at risk of dehydration, hypothermia, and kidney and liver failure from over-exertion while under its effects.

For more information, click here to read the full article from The Washington Examiner.

*As an Amazon Associate I earn from qualifying purchases